Supplemental Qualifiers for DS

Data Value
Stage 1, Age 18 to 55, Low dose level (10mcg), 21 Day (BNT162b1 or PBO)
Stage 1, Age 18 to 55, Medium dose level (30mcg), 21 Day (BNT162b1 or PBO)
Stage 1, Age 18 to 55, High dose level (100mcg), 21 Day (BNT162b1 or PBO)
Stage 1, Age 65 to 85, Low dose level (10mcg), 21 Day (BNT162b1 or PBO)
Stage 1, Age 65 to 85, Low-Mid dose level (20mcg), 21 Day (BNT162b1 or PBO)
Stage 1, Age 65 to 85, Medium dose level (30mcg), 21 Day (BNT162b1 or PBO)
Stage 1, Age 18 to 55, Low-Mid dose level (20mcg), 21 Day (BNT162b1 or PBO)
Stage 1, Age 18 to 55, Low dose level (10mcg), 21 Day (BNT162b2 or PBO)
Stage 1, Age 18 to 55, Low-Mid dose level (20mcg), 21 Day (BNT162b2 or PBO)
Stage 1, Age 65 to 85, Low-Mid dose level (20mcg), 21 Day (BNT162b2 or PBO)
Stage 1, Age 65 to 85, Medium dose level (30mcg), 21 Day (BNT162b2 or PBO)
Stage 1, Age 18 to 55, Medium dose level (30mcg), 21 Day (BNT162b2 or PBO)
Stage 1, Age 65 to 85, Low dose level (10mcg), 21 Day (BNT162b2 or PBO)